Bioassay of lead dimethyldithiocarbamate for possible carcinogenicity / Carcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health.

Format Electronic
Publication InfoBethesda, Md. : U. S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1979.
Description1 online resource (xi, 98 pages) : illustrations.
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo36242
Subjects

Other author/creatorFrederick Cancer Research Center.
Other author/creatorNational Cancer Institute (U.S.). Division of Cancer Cause and Prevention.
Other author/creatorNational Institutes of Health (U.S.)
Other author/creatorCarcinogenesis Testing Program (U.S.)
SeriesNational Cancer Institute carcinogenesis technical report series ; no. 151
DHEW publication ; no. (NIH) 79-1707
National Cancer Institute carcinogenesis technical report series ; no. 151. ^A1107162
DHEW publication no. (NIH) 79-1707. ^A204
General noteTitle from title screen (viewed on June 4, 2013).
General note"CAS no. 19010-66-3."
General note"NCI-CG-TR-151."
General noteConducted for the Carcinogenesis Testing Program, National Cancer Institute, by Frederick Cancer Research Center.
Issued in other formPrint version: National Cancer Institute (U.S.). Division of Cancer Cause and Prevention. Bioassay of lead dimethyldithiocarbamate for possible carcinogenicity
Technical rpt#CAS no. 19010-66-3
Technical rpt numberNCI-CG-TR-151
GPO item number0507-G-12 (online)
Govt. docs number HE 20.3159/2:151

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available